{"transactions":[{"id":1831216,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T21:00:38.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":14550,"derivative":{"exercise_price":1.22,"expiration_date":"2033-07-09","underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001209191-23-042101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123042101/doc4.xml","form_type":"4"}},{"id":1831215,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-12T21:00:38.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":4466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":8932,"source":{"system":"sec-edgar","filing":"0001209191-23-042101","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919123042101/doc4.xml","form_type":"4"}},{"id":1886583,"issuer":{"id":113330,"kind":"organization","name":"Orion Biotech Opportunities Corp.","symbol":"ORIA"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B ordinary shares","published_at":"2023-05-18T16:05:11.000Z","date":"2023-05-17","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On April 21, 2023, the Issuer announced that it will not consummate an initial business combination within the time period required. Pursuant to the Issuer's Amended and Restated Memorandum and Articles of Association (the \"Articles\") and in connection with the winding up of the Issuer, the Class B ordinary shares, par value $0.0001, held by the Reporting Person were surrendered for no compensation on May 17, 2023."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-23-041170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1340543/000121390023041170/ownership.xml","form_type":"4"}},{"id":2233355,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-14T20:15:16.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":14550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":14550,"derivative":{"exercise_price":2.05,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":14550},"source":{"system":"sec-edgar","filing":"0001209191-22-036666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122036666/doc4.xml","form_type":"4"}},{"id":2233354,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T20:15:16.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":4466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (the \"RSUs\"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date."}],"balance_after":4466,"source":{"system":"sec-edgar","filing":"0001209191-22-036666","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919122036666/doc4.xml","form_type":"4"}},{"id":2878147,"issuer":{"id":5029,"kind":"organization","name":"Faeth Therapeutics, Inc.","symbol":"FTH"},"owners":[{"id":111453,"kind":"person","name":"Broder Samuel","position":1,"cik":"0001340543","reported_name":"Broder Samuel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2021-02-05T21:35:43.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth (1/36th) of the options granted shall vest and become exercisable each month following February 3, 2021, the Vesting Commencement Date, over three years such that the options shall be 100% vested on the third anniversary of the Vesting Commencement Date, subject to the grantee's Continuous Service (as defined in the 2021 Equity Incentive Plan) through each such vesting date."}],"balance_after":16666,"derivative":{"exercise_price":19,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001209191-21-008074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1829802/000120919121008074/doc4.xml","form_type":"4"}}]}